Market Size and Overview The global CAR T-cell therapy market is expected to grow from USD 4.83 Bn in 2026 to USD 18.46 Bn by 2033, registering a compound annual growth rate (CAGR) of 21.1%.  This significant market growth highlights increasing adoption of Car T therapies across hematological malignancies and solid tumors, as reflected by rising clinical approvals and expanded...